Dr. Kazi Salahuddin, MD

NPI: 1558306225
Total Payments
$4,840
2024 Payments
$751.24
Companies
13
Transactions
95
Medicare Patients
204
Medicare Billing
$31,013

Payment Breakdown by Category

Food & Beverage$4,551 (94.0%)
Education$288.34 (6.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,551 91 94.0%
Education $288.34 4 6.0%

Top Paying Companies

Company Total Records Latest Year
Alkermes, Inc. $1,699 20 $0 (2024)
Allergan, Inc. $941.30 34 $0 (2020)
Teva Pharmaceuticals USA, Inc. $421.73 7 $0 (2024)
Sunovion Pharmaceuticals Inc. $385.97 7 $0 (2018)
Otsuka America Pharmaceutical, Inc. $325.11 10 $0 (2024)
AbbVie Inc. $285.81 3 $0 (2023)
ITI, Inc. $208.52 4 $0 (2023)
Neurocrine Biosciences, Inc. $165.33 3 $0 (2024)
Shire North American Group Inc $140.23 2 $0 (2018)
Janssen Pharmaceuticals, Inc $99.99 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $751.24 14 Alkermes, Inc. ($227.41)
2023 $878.00 14 Alkermes, Inc. ($356.76)
2022 $830.28 14 Alkermes, Inc. ($410.62)
2021 $433.07 6 Alkermes, Inc. ($224.63)
2020 $376.71 4 Alkermes, Inc. ($354.70)
2019 $488.23 16 Allergan Inc. ($363.27)
2018 $653.18 18 Allergan Inc. ($490.55)
2017 $429.04 9 Sunovion Pharmaceuticals Inc. ($238.57)

All Payment Transactions

95 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
11/14/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $84.23 General
Category: Psychiatry/Psychology
10/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $28.60 General
Category: PSYCHIATRY
09/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $38.31 General
Category: SCHIZOPHRENIA
08/15/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $29.57 General
Category: PSYCHIATRY
05/09/2024 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $89.60 General
Category: CNS
04/25/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII Food and Beverage In-kind items and services $123.11 General
Category: PSYCHIATRY
03/22/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $21.15 General
Category: PSYCHIATRY
03/21/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $0.58 General
Category: PSYCHIATRY
03/15/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $27.72 General
Category: CNS
02/21/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $110.09 General
Category: CNS
02/16/2024 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $21.06 General
Category: BH
02/08/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $127.80 General
Category: Neurology
01/31/2024 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $22.52 General
Category: PSYCHIATRY
01/17/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.90 General
Category: Neuropsychiatry
12/07/2023 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $119.86 General
Category: Neuropsychiatry
11/17/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $122.76 General
Category: CNS
11/17/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $23.08 General
Category: OUD
11/17/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $17.61 General
Category: CNS
09/19/2023 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $27.71 General
Category: NEUROLOGY
08/17/2023 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $30.37 General
Category: Neurology
07/21/2023 Otsuka America Pharmaceutical, Inc. ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA Food and Beverage In-kind items and services $25.47 General
Category: PSYCHIATRY
06/14/2023 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $13.90 General
Category: Neurology
04/28/2023 Alkermes, Inc. LYBALVI (Drug), LYBALVI, LYBALVI Food and Beverage In-kind items and services $99.76 General
Category: CNS
04/10/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Education In-kind items and services $99.99 General
Category: Neuroscience
03/17/2023 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $22.61 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 47 128 $11,418 $5,687
2022 3 50 104 $12,829 $5,296
2021 3 56 191 $30,800 $10,575
2020 3 51 175 $23,118 $9,454
Total Patients
204
Total Services
598
Medicare Billing
$31,013
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 20 52 $3,925 $2,729 69.5%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 12 41 $5,464 $1,595 29.2%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 15 35 $2,029 $1,363 67.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 16 41 $3,095 $2,141 69.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 18 37 $8,191 $2,107 25.7%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 16 26 $1,544 $1,049 67.9%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 25 79 $22,717 $4,501 19.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 16 66 $4,982 $3,650 73.3%
90833 Psychotherapy performed with evaluation and management visit, 30 minutes Office 2021 15 46 $3,101 $2,425 78.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 17 81 $6,114 $4,096 67.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 17 47 $13,835 $2,833 20.5%
90833 Psychotherapy, 30 minutes Office 2020 17 47 $3,169 $2,524 79.7%

About Dr. Kazi Salahuddin, MD

Dr. Kazi Salahuddin, MD is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558306225.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kazi Salahuddin, MD has received a total of $4,840 in payments from pharmaceutical and medical device companies, with $751.24 received in 2024. These payments were reported across 95 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($4,551).

As a Medicare-enrolled provider, Salahuddin has provided services to 204 Medicare beneficiaries, totaling 598 services with total Medicare billing of $31,013. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Providence, RI
  • Active Since 06/18/2006
  • Last Updated 03/31/2009
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • NPI Number 1558306225

Products in Payments

  • VRAYLAR (Drug) $1,227
  • ARISTADA (Drug) $1,054
  • LYBALVI (Drug) $638.09
  • LATUDA (Drug) $385.97
  • CAPLYTA (Drug) $208.52
  • UZEDY (Drug) $172.07
  • ABILIFY MAINTENA (Drug) $167.36
  • INGREZZA (Drug) $165.33
  • MYDAYIS (Drug) $140.23
  • AUSTEDO (Drug) $138.21
  • INVEGA SUSTENNA (Drug) $99.99
  • COBENFY (Drug) $84.23
  • REXULTI (Drug) $80.78
  • FANAPT (Drug) $38.31
  • NUEDEXTA (Drug) $27.71
  • ABILIFY ASIMTUFII (Drug) $25.47
  • ABILIFY MYCITE (Drug) $23.79
  • SUBLOCADE (Drug) $23.08
  • PERSERIS (Drug) $21.06
  • VIVITROL (Drug) $7.43

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Providence